Gabelli & Co Investment Advisers’s SOC Telemed, Inc. Class A Common Stock TLMD Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio TLMD Stock Details TLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-158,587	Closed	-$474K	–	557
2022 Q1	$474K	Buy	+158,587	New	+$349K	0.06%	233
2020 Q4	–	Sell	-117,809	Closed	-$1.2M	–	353
2020 Q3	$1.2M	Sell	117,809 -136,091	-54%	-$1.4M	0.22%	92
2020 Q2	$2.54M	Hold	253,900	–	–	0.58%	37
2020 Q1	$2.46M	Buy	+253,900	New	+$2.51M	0.37%	53

Gabelli & Co Investment Advisers's TLMD Position: Q2 2022 in Review

Gabelli & Co Investment Advisers sold out of SOC Telemed, Inc. Class A Common Stock (TLMD) in Q2 2022, closing a stake of 158,587 shares — an estimated $474K sold.

Gabelli & Co Investment Advisers first reported a position in TLMD in Q1 2020 and held it in 4 quarters. The position peaked at $2.54M in Q2 2020. 0 funds tracked by Wall St. Rank hold TLMD as of Q2 2022.

Gabelli & Co Investment Advisers reported no remaining SOC Telemed, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 158,587 SOC Telemed, Inc. Class A Common Stock shares in Q2 2022, an estimated $474K.
Gabelli & Co Investment Advisers first reported a position in SOC Telemed, Inc. Class A Common Stock in Q1 2020 and held it in 4 quarters.
Gabelli & Co Investment Advisers's SOC Telemed, Inc. Class A Common Stock position peaked at $2.54M in Q2 2020.
0 funds tracked by Wall St. Rank held SOC Telemed, Inc. Class A Common Stock as of Q2 2022.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2022, filed 12 Aug 2022.